- Home
- ALCO vs FULC Comparison
ALCO vs FULC Comparison
Compare ALCO & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALCO
- FULC
- Stock Information
- Founded
- ALCO 1960
- FULC 2015
- Country
- ALCO United States
- FULC United States
- Employees
- ALCO N/A
- FULC N/A
- Industry
- ALCO
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- ALCO
- FULC Health Care
- Exchange
- ALCO Nasdaq
- FULC Nasdaq
- Market Cap
- ALCO 186.1M
- FULC 221.5M
- IPO Year
- ALCO N/A
- FULC 2019
- Fundamental
- Price
- ALCO $26.20
- FULC $4.34
- Analyst Decision
- ALCO
- FULC Hold
- Analyst Count
- ALCO 0
- FULC 10
- Target Price
- ALCO N/A
- FULC $7.44
- AVG Volume (30 Days)
- ALCO 38.2K
- FULC 791.7K
- Earning Date
- ALCO 02-05-2025
- FULC 11-13-2024
- Dividend Yield
- ALCO 0.76%
- FULC N/A
- EPS Growth
- ALCO 279.17
- FULC N/A
- EPS
- ALCO 0.91
- FULC N/A
- Revenue
- ALCO $46,643,000.00
- FULC $80,871,000.00
- Revenue This Year
- ALCO $91.35
- FULC $2,820.53
- Revenue Next Year
- ALCO N/A
- FULC N/A
- P/E Ratio
- ALCO $28.32
- FULC N/A
- Revenue Growth
- ALCO 17.06
- FULC 2987.86
- 52 Week Low
- ALCO $24.14
- FULC $2.86
- 52 Week High
- ALCO $30.75
- FULC $13.70
- Technical
- Relative Strength Index (RSI)
- ALCO 49.58
- FULC 63.62
- Support Level
- ALCO $25.30
- FULC $3.94
- Resistance Level
- ALCO $26.90
- FULC $4.64
- Average True Range (ATR)
- ALCO 0.63
- FULC 0.33
- MACD
- ALCO -0.09
- FULC 0.08
- Stochastic Oscillator
- ALCO 35.14
- FULC 81.90
About ALCO Alico Inc.
Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.